Author

Manuela Stoicescu

University of Oradea ,Faculty of Medicine and Pharmacy , Medical Disciplines Department - Cited by 52 - Internal Medicine

Biography

Maneula Stoicescu is working as a faulty of Medicine and Pharmacy at Medical Disciplines Department at University of Oradea which is located in Romania. Maneula's research interrests include Myocardial Infraction, Health Education, Medical Education.
Title
Cited by
Year
The role of increased level of plasma renin in etiopathogenic arterial hypertension in the young
M Stoicescu, C Csepento, G Mutiu, S BungauRom J Morphol Embriol 52 (1 Suppl), 419-423, 2011201
15
2011
Carcinogenic uterine risk of repeated abortions: Hormonal receptors tumoral expression
M Stoicescu, SG Bungău, DM Ţiţ, G Muţiu, AL Purza, VC Iovan, OL PopRom. J. Morphol. Embriol 58 (4), 1429-1434, 2017201
13
2017
The Risk of Sudden Decrease of Severe Arterial Hypertension
M StoicescuJournal of Clinical & Experimental Cardiology USA - Journal Impact Factor 0 …, 2016201
5
2016
Kidney Tumor in Pregnancy
M StoicescuJournal of Nephrology & Therapeutics USA - Journal Impact Factor 1 3 (3), 4, 2013201
5
2013
The Very Dangerous Risk of Using Pills for Weight Loss and Contraceptive Pills in Same Time
M StoicescuJournal of Developing Drugs USA - Journal Impact Factor 0.97 3 (1), , 01401
2
2014
The Risk of Hormone Anabolic Steroids and Oral Contraceptives Consumption in the Young
M StoicescuJournal of Developing Drugs USA - Journal Impact Factor 0.97 (3), 4, 01301
2
2013
Controversial in Menopausal Hormone Replacement Therapy
M StoicescuJournal of Developing Drugs USA - Journal Impact Factor 0.97* 5 (3), 3, 20620
1
2016
Hemathologic Risk of Anabolic Steroids
M StoicescuJournal of Developing Drugs USA - Journal Impact Factor 0.97 3 (), 2, 20420
1
2014
Osteogenesis imperfecta (Oi): A case report and diagnosis thinking beyond bone fracture
M StoicescuJournal of Molecular and Genetic Medicine 7, 00, 20420
1
2014
The Risk of Administration Plasma
M StoicescuJournal of Developing Drugs USA - Journal Impact Factor 0.97 2 (2), 3, 20320
1
2013
The Risk of Breast Carcinoma with Interferon Plus Ribavarin Therapy during Treatment of Chronic Hepatitis C Virus Infection-A Case Report
M StoicescuJournal of Developing Drugs USA - Journal Impact Factor 0.97 2 (1), 2, 20131201
1
2013